|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
58,625,000 |
Market
Cap: |
1.76(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$22.72 - $37.28 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
98,505 |
119,208 |
124,343 |
450,780 |
Total Sell Value |
$3,345,846 |
$3,929,526 |
$4,091,741 |
$15,155,681 |
Total People Sold |
1 |
5 |
5 |
6 |
Total Sell Transactions |
6 |
10 |
11 |
37 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Patrick Gregory S |
Sr VP, Chief Financial Officer |
|
2019-02-27 |
4 |
AS |
$41.53 |
$830,650 |
D/D |
(20,000) |
47,896 |
|
- |
|
Patrick Gregory S |
Sr VP, Chief Financial Officer |
|
2019-02-27 |
4 |
OE |
$9.13 |
$182,600 |
D/D |
20,000 |
67,896 |
|
- |
|
Khattar Jack A. |
President, CEO |
|
2019-01-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
400 |
2,900 |
|
- |
|
Khattar Jack A. |
President, CEO |
|
2019-01-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,200 |
453,065 |
|
- |
|
Siebert John M |
Director |
|
2018-08-20 |
4 |
OE |
$7.90 |
$137,806 |
D/D |
16,179 |
35,742 |
|
- |
|
Patrick Gregory S |
VP, Chief Financial Officer |
|
2018-07-02 |
4 |
AS |
$56.63 |
$1,981,914 |
D/D |
(35,000) |
55,975 |
|
- |
|
Patrick Gregory S |
VP, Chief Financial Officer |
|
2018-07-02 |
4 |
OE |
$9.13 |
$321,750 |
D/D |
35,000 |
90,975 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-06-29 |
4 |
AS |
$59.90 |
$263,153 |
D/D |
(4,393) |
0 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-06-28 |
4 |
AS |
$59.94 |
$203,899 |
D/D |
(3,402) |
4,393 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-06-28 |
4 |
OE |
$9.13 |
$2,693 |
D/D |
295 |
7,795 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-06-21 |
4 |
AS |
$60.00 |
$432,323 |
D/D |
(7,205) |
7,500 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-06-21 |
4 |
OE |
$9.13 |
$65,782 |
D/D |
7,205 |
14,705 |
|
- |
|
Schwabe Stefan K.f. |
Executive VP R&D, CMO |
|
2018-06-18 |
4 |
AS |
$54.39 |
$3,263,352 |
D/D |
(60,000) |
1,967 |
|
- |
|
Schwabe Stefan K.f. |
Executive VP R&D, CMO |
|
2018-06-18 |
4 |
OE |
$7.90 |
$527,600 |
D/D |
60,000 |
61,967 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-05-15 |
4 |
AS |
$57.93 |
$455,759 |
D/D |
(7,868) |
7,500 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-05-15 |
4 |
OE |
$9.13 |
$71,875 |
D/D |
7,868 |
15,000 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-05-11 |
4 |
AS |
$52.03 |
$2,568,169 |
D/D |
(47,132) |
7,500 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-05-11 |
4 |
OE |
$7.90 |
$362,500 |
D/D |
42,132 |
18,382 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-05-10 |
4 |
AS |
$49.88 |
$997,544 |
D/D |
(20,000) |
12,500 |
|
- |
|
Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
|
2018-05-10 |
4 |
OE |
$7.90 |
$158,000 |
D/D |
20,000 |
32,500 |
|
- |
|
Vaughn Victor |
Sr. VP of Sales & Marketing |
|
2018-04-19 |
4 |
AS |
$49.03 |
$384,855 |
D/D |
(7,850) |
9,344 |
|
- |
|
Vaughn Victor |
Sr. VP of Sales & Marketing |
|
2018-04-19 |
4 |
OE |
$25.30 |
$198,605 |
D/D |
7,850 |
17,194 |
|
- |
|
Vaughn Victor |
Sr. VP of Sales & Marketing |
|
2018-04-18 |
4 |
AS |
$47.06 |
$470,617 |
D/D |
(10,000) |
9,344 |
|
- |
|
Vaughn Victor |
Sr. VP of Sales & Marketing |
|
2018-04-18 |
4 |
OE |
$12.98 |
$176,000 |
D/D |
10,000 |
19,344 |
|
- |
|
Vaughn Victor |
Sr. VP of Sales and Marketing |
|
2018-04-05 |
4 |
AS |
$45.33 |
$2,719,770 |
D/D |
(60,000) |
9,344 |
|
- |
|
345 Records found
|
|
Page 9 of 14 |
|
|